Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Sirona Biochem Corp.
  6. Summary
    SBM   CA82967M1005

SIRONA BIOCHEM CORP.

(SBM)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Bourse De Toronto
09/10/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
0.185(c) 0.18(c) 0.19(c) 0.19(c) 0.21(c) Last
366 594 86 666 17 737 33 669 55 466 Volume
-5.13% -2.70% +5.56% 0.00% +10.53% Change
More quotes
Estimated financial data (e)
Sales 2019 0,14 M 0,11 M 0,11 M
Net income 2019 -4,55 M -3,56 M -3,56 M
Net cash position 2019 2,19 M 1,71 M 1,71 M
P/E ratio 2019 -19,7x
Yield 2019 -
Sales 2020 0,11 M 0,08 M 0,08 M
Net income 2020 -4,13 M -3,24 M -3,24 M
Net cash position 2020 0,29 M 0,23 M 0,23 M
P/E ratio 2020 -13,7x
Yield 2020 -
Capitalization 48,4 M 37,9 M 37,9 M
EV / Sales 2019 709x
EV / Sales 2020 532x
Nbr of Employees -
Free-Float 89,1%
More Financials
Company
Sirona Biochem Corp. is a Canada-based development-stage cosmetic ingredient and drug discovery company with a technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. It is engaged in the development of cosmetic and pharmaceutical active ingredients, which are licensed to its partners. The Company has six product lines: SGLT2 Inhibitor,... 
More about the company
All news about SIRONA BIOCHEM CORP.
06/30SIRONA BIOCHEM : R E P E A T -- Sirona Biochem CEO Quarterly Update Q2 2021/
AQ
06/30SIRONA BIOCHEM : CEO Quarterly Update Q2 2021
AQ
06/29Sirona Biochem Corp. Reports Earnings Results for the Second Quarter Ended Ap..
CI
03/31SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Reports Excellent Results in New ..
AQ
03/31SIRONA BIOCHEM : Reports "Excellent Results" in New Clinical Study on TFC-1067
MT
03/31SIRONA BIOCHEM : Reports Excellent Results in New Clinical Study on TFC-1067
AQ
03/31Sirona Biochem Reports Excellent Results in New Clinical Study on TFC-1067
CI
03/10SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Announces Launch of First Commerc..
AQ
03/10SIRONA BIOCHEM : Says First Commercial Product Containing TFC-1067 Compound to b..
MT
03/10SIRONA BIOCHEM : Announces Launch of First Commercial Product Containing TFC-106..
AQ
03/10Sirona Biochem Announces Launch of First Commercial Product Containing TFC-10..
CI
03/03Sirona Biochem Corp. Auditor Raises 'Going Concern' Doubt
CI
03/03Sirona Biochem Corp. Reports Earnings Results for the Full Year Ended October..
CI
02/24SIRONA BIOCHEM : R E P E A T -- Sirona Biochem CEO Quarterly Update Q1 2021/
AQ
02/24SIRONA BIOCHEM : CEO Quarterly Update Q1 2021
AQ
More news
News in other languages on SIRONA BIOCHEM CORP.
03/10IRW-NEWS : Sirona Biochem Corp.: Sirona Biochem gibt Markteinführung des ersten ..
03/10IRW-PRESS : Sirona Biochem Corp.: Sirona Biochem gibt Markteinführung des ersten..
02/24IRW-NEWS : Sirona Biochem Corp.: Sirona Biochem: Vierteljährliches Update des CE..
02/24IRW-PRESS : Sirona Biochem Corp.: Sirona Biochem: -2-
02/24IRW-PRESS : Sirona Biochem Corp.: Sirona Biochem: Vierteljährliches Update des C..
More news
Chart SIRONA BIOCHEM CORP.
Duration : Period :
Sirona Biochem Corp. Technical Analysis Chart | SBM | CA82967M1005 | MarketScreener
Income Statement Evolution
Managers and Directors
Howard Jarman Verrico Chairman, Chief Executive Officer & Secretary
Christopher D. Hopton CFO & Non-Independent Director
Géraldine Deliencourt-Godefroy Director & Chief Scientific Officer
Michelle Seltenrich Vice President-Operations
Alex Sandro Marazzi Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SIRONA BIOCHEM CORP.-35.38%38
MODERNA, INC.321.80%177 867
LONZA GROUP AG36.36%62 278
IQVIA HOLDINGS INC.43.91%49 407
CELLTRION, INC.-23.26%31 021
SEAGEN INC.-12.32%27 940